Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Antipsychotic Agents"" wg kryterium: Temat


Starter badań:

Tytuł :
Differences in Antipsychotic Treatment Discontinuation Among Veterans With Schizophrenia in the U.S. Department of Veterans Affairs.
Autorzy :
Weiser M; Stanley Medical Research Institute, Kensington, Md. (Weiser); Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel (Weiser, Levi); Department of Psychiatry, Tel Aviv University, Ramat Aviv, Israel (Weiser); Department of Psychiatry, University of Illinois, Chicago (Davis); VA Capitol Healthcare Network (VISN 5) Mental Illness Research, Education, and Clinical Center (MIRECC), Baltimore (Brown, Medoff, Kreyenbuhl); Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore (Brown; Medoff, Kreyenbuhl); Johns Hopkins School of Nursing, Baltimore (Slade); Department of Psychiatry, Division of Psychiatric Services Research, University of Maryland School of Medicine, Baltimore (Fang); Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore (Buchanan); and University of Nicosia Medical School, Nicosia, Cyprus (Davison).
Davis JM; Stanley Medical Research Institute, Kensington, Md. (Weiser); Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel (Weiser, Levi); Department of Psychiatry, Tel Aviv University, Ramat Aviv, Israel (Weiser); Department of Psychiatry, University of Illinois, Chicago (Davis); VA Capitol Healthcare Network (VISN 5) Mental Illness Research, Education, and Clinical Center (MIRECC), Baltimore (Brown, Medoff, Kreyenbuhl); Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore (Brown; Medoff, Kreyenbuhl); Johns Hopkins School of Nursing, Baltimore (Slade); Department of Psychiatry, Division of Psychiatric Services Research, University of Maryland School of Medicine, Baltimore (Fang); Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore (Buchanan); and University of Nicosia Medical School, Nicosia, Cyprus (Davison).
Brown CH; Stanley Medical Research Institute, Kensington, Md. (Weiser); Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel (Weiser, Levi); Department of Psychiatry, Tel Aviv University, Ramat Aviv, Israel (Weiser); Department of Psychiatry, University of Illinois, Chicago (Davis); VA Capitol Healthcare Network (VISN 5) Mental Illness Research, Education, and Clinical Center (MIRECC), Baltimore (Brown, Medoff, Kreyenbuhl); Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore (Brown; Medoff, Kreyenbuhl); Johns Hopkins School of Nursing, Baltimore (Slade); Department of Psychiatry, Division of Psychiatric Services Research, University of Maryland School of Medicine, Baltimore (Fang); Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore (Buchanan); and University of Nicosia Medical School, Nicosia, Cyprus (Davison).
Slade EP; Stanley Medical Research Institute, Kensington, Md. (Weiser); Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel (Weiser, Levi); Department of Psychiatry, Tel Aviv University, Ramat Aviv, Israel (Weiser); Department of Psychiatry, University of Illinois, Chicago (Davis); VA Capitol Healthcare Network (VISN 5) Mental Illness Research, Education, and Clinical Center (MIRECC), Baltimore (Brown, Medoff, Kreyenbuhl); Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore (Brown; Medoff, Kreyenbuhl); Johns Hopkins School of Nursing, Baltimore (Slade); Department of Psychiatry, Division of Psychiatric Services Research, University of Maryland School of Medicine, Baltimore (Fang); Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore (Buchanan); and University of Nicosia Medical School, Nicosia, Cyprus (Davison).
Fang LJ; Stanley Medical Research Institute, Kensington, Md. (Weiser); Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel (Weiser, Levi); Department of Psychiatry, Tel Aviv University, Ramat Aviv, Israel (Weiser); Department of Psychiatry, University of Illinois, Chicago (Davis); VA Capitol Healthcare Network (VISN 5) Mental Illness Research, Education, and Clinical Center (MIRECC), Baltimore (Brown, Medoff, Kreyenbuhl); Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore (Brown; Medoff, Kreyenbuhl); Johns Hopkins School of Nursing, Baltimore (Slade); Department of Psychiatry, Division of Psychiatric Services Research, University of Maryland School of Medicine, Baltimore (Fang); Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore (Buchanan); and University of Nicosia Medical School, Nicosia, Cyprus (Davison).
Medoff DR; Stanley Medical Research Institute, Kensington, Md. (Weiser); Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel (Weiser, Levi); Department of Psychiatry, Tel Aviv University, Ramat Aviv, Israel (Weiser); Department of Psychiatry, University of Illinois, Chicago (Davis); VA Capitol Healthcare Network (VISN 5) Mental Illness Research, Education, and Clinical Center (MIRECC), Baltimore (Brown, Medoff, Kreyenbuhl); Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore (Brown; Medoff, Kreyenbuhl); Johns Hopkins School of Nursing, Baltimore (Slade); Department of Psychiatry, Division of Psychiatric Services Research, University of Maryland School of Medicine, Baltimore (Fang); Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore (Buchanan); and University of Nicosia Medical School, Nicosia, Cyprus (Davison).
Buchanan RW; Stanley Medical Research Institute, Kensington, Md. (Weiser); Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel (Weiser, Levi); Department of Psychiatry, Tel Aviv University, Ramat Aviv, Israel (Weiser); Department of Psychiatry, University of Illinois, Chicago (Davis); VA Capitol Healthcare Network (VISN 5) Mental Illness Research, Education, and Clinical Center (MIRECC), Baltimore (Brown, Medoff, Kreyenbuhl); Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore (Brown; Medoff, Kreyenbuhl); Johns Hopkins School of Nursing, Baltimore (Slade); Department of Psychiatry, Division of Psychiatric Services Research, University of Maryland School of Medicine, Baltimore (Fang); Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore (Buchanan); and University of Nicosia Medical School, Nicosia, Cyprus (Davison).
Levi L; Stanley Medical Research Institute, Kensington, Md. (Weiser); Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel (Weiser, Levi); Department of Psychiatry, Tel Aviv University, Ramat Aviv, Israel (Weiser); Department of Psychiatry, University of Illinois, Chicago (Davis); VA Capitol Healthcare Network (VISN 5) Mental Illness Research, Education, and Clinical Center (MIRECC), Baltimore (Brown, Medoff, Kreyenbuhl); Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore (Brown; Medoff, Kreyenbuhl); Johns Hopkins School of Nursing, Baltimore (Slade); Department of Psychiatry, Division of Psychiatric Services Research, University of Maryland School of Medicine, Baltimore (Fang); Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore (Buchanan); and University of Nicosia Medical School, Nicosia, Cyprus (Davison).
Davidson M; Stanley Medical Research Institute, Kensington, Md. (Weiser); Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel (Weiser, Levi); Department of Psychiatry, Tel Aviv University, Ramat Aviv, Israel (Weiser); Department of Psychiatry, University of Illinois, Chicago (Davis); VA Capitol Healthcare Network (VISN 5) Mental Illness Research, Education, and Clinical Center (MIRECC), Baltimore (Brown, Medoff, Kreyenbuhl); Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore (Brown; Medoff, Kreyenbuhl); Johns Hopkins School of Nursing, Baltimore (Slade); Department of Psychiatry, Division of Psychiatric Services Research, University of Maryland School of Medicine, Baltimore (Fang); Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore (Buchanan); and University of Nicosia Medical School, Nicosia, Cyprus (Davison).
Kreyenbuhl J; Stanley Medical Research Institute, Kensington, Md. (Weiser); Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel (Weiser, Levi); Department of Psychiatry, Tel Aviv University, Ramat Aviv, Israel (Weiser); Department of Psychiatry, University of Illinois, Chicago (Davis); VA Capitol Healthcare Network (VISN 5) Mental Illness Research, Education, and Clinical Center (MIRECC), Baltimore (Brown, Medoff, Kreyenbuhl); Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore (Brown; Medoff, Kreyenbuhl); Johns Hopkins School of Nursing, Baltimore (Slade); Department of Psychiatry, Division of Psychiatric Services Research, University of Maryland School of Medicine, Baltimore (Fang); Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore (Buchanan); and University of Nicosia Medical School, Nicosia, Cyprus (Davison).
Pokaż więcej
Źródło :
The American journal of psychiatry [Am J Psychiatry] 2021 Oct 01; Vol. 178 (10), pp. 932-940. Date of Electronic Publication: 2021 Jul 14.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Antipsychotic Agents*/classification
Antipsychotic Agents*/therapeutic use
Schizophrenia*/diagnosis
Schizophrenia*/epidemiology
Schizophrenia*/therapy
Veterans*/psychology
Veterans*/statistics & numerical data
Hospitalization/*statistics & numerical data
Outpatients/*statistics & numerical data
Administration, Oral ; Comparative Effectiveness Research ; Delayed-Action Preparations/therapeutic use ; Female ; Humans ; Male ; Middle Aged ; Outcome Assessment, Health Care ; Treatment Outcome ; United States/epidemiology ; United States Department of Veterans Affairs/statistics & numerical data ; Withholding Treatment/statistics & numerical data
Czasopismo naukowe
Tytuł :
[Antipsychotic prescription prevalence and metabolic monitoring of patients under chronic treatment].
Autorzy :
Vivacqua MN; Hospital Italiano de Buenos Aires.; .
Abudarham T; Hospital Italiano de Buenos Aires.; .
Pagotto V; Hospital Italiano de Buenos Aires.
Faccioli JL; Hospital Italiano de Buenos Aires.
Pokaż więcej
Transliterated Title :
[Prevalencia en la prescripción de antipsicóticos y monitoreo metabólico en pacientes bajo tratamiento crónico].
Źródło :
Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) [Rev Fac Cien Med Univ Nac Cordoba] 2021 Sep 01; Vol. 78 (3), pp. 276-282. Date of Electronic Publication: 2021 Sep 01.
Typ publikacji :
Journal Article
MeSH Terms :
Antipsychotic Agents*/adverse effects
Aged ; Cohort Studies ; Female ; Humans ; Male ; Prescriptions ; Prevalence ; Retrospective Studies
Czasopismo naukowe
Tytuł :
A meta-analysis of effectiveness of real-world studies of antipsychotics in schizophrenia: Are the results consistent with the findings of randomized controlled trials?
Autorzy :
Katona L; Independent Researcher, Budapest, Hungary.
Bitter I; Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary.
Czobor P; Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary. .
Pokaż więcej
Źródło :
Translational psychiatry [Transl Psychiatry] 2021 Oct 06; Vol. 11 (1), pp. 510. Date of Electronic Publication: 2021 Oct 06.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Antipsychotic Agents*/therapeutic use
Schizophrenia*/drug therapy
Humans ; Olanzapine ; Randomized Controlled Trials as Topic ; Risperidone/therapeutic use
Czasopismo naukowe
Tytuł :
Hemodynamic Impact of Drug Interactions With Epinephrine and Antipsychotics Under General Anesthesia With Propofol.
Autorzy :
Shionoya Y; Department of Dental Anesthesia, The Nippon Dental University Hospital, Tokyo, Japan.
Nakamura E; Department of Dental Anesthesia, The Nippon Dental University Hospital, Tokyo, Japan.
Tsujimoto G; Department of Dental Anesthesia, The Nippon Dental University Hospital, Tokyo, Japan.
Koyata T; Department of Dental Anesthesia, The Nippon Dental University Hospital, Tokyo, Japan.
Yasuda A; Department of Dental Anesthesia, The Nippon Dental University Hospital, Tokyo, Japan.
Nakamura K; Department of Dental Anesthesia, The Nippon Dental University Hospital, Tokyo, Japan.
Sunada K; Department of Dental Anesthesiology, The Nippon Dental University School of Life Dentistry, Tokyo, Japan.
Pokaż więcej
Źródło :
Anesthesia progress [Anesth Prog] 2021 Oct 01; Vol. 68 (3), pp. 141-145.
Typ publikacji :
Journal Article
MeSH Terms :
Antipsychotic Agents*/adverse effects
Propofol*/adverse effects
Anesthesia, General/adverse effects ; Anesthetics, Local/pharmacology ; Blood Pressure ; Drug Interactions ; Epinephrine/pharmacology ; Heart Rate ; Hemodynamics ; Humans ; Lidocaine/pharmacology ; Prospective Studies
Czasopismo naukowe
Tytuł :
Gluteal muscle damage and rhabdomyolysis after olanzapine poisoning: a case report.
Autorzy :
Yu G; Department of Poisoning and Occupational Diseases, 12589Shandong University, Emergency, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
Cui S; Department of Poisoning and Occupational Diseases, 12589Shandong University, Emergency, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.; School of Public Health, Cheeloo College of Medicine, 12589Shandong University, Shandong University, Jinan, Shandong, China.
Jian T; Department of Poisoning and Occupational Diseases, 12589Shandong University, Emergency, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
Sun C; Department of Poisoning and Occupational Diseases, 12589Shandong University, Emergency, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
Shi L; Department of Poisoning and Occupational Diseases, 12589Shandong University, Emergency, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.; School of Public Health, Cheeloo College of Medicine, 12589Shandong University, Shandong University, Jinan, Shandong, China.
Li Y; Department of Poisoning and Occupational Diseases, 12589Shandong University, Emergency, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
Kan B; School of Nursing, Cheeloo College of Medicine, Shandong University, Shandong, China.; Department of Geriatric Medicine, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
Jian X; Department of Poisoning and Occupational Diseases, 12589Shandong University, Emergency, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.; School of Public Health, Cheeloo College of Medicine, 12589Shandong University, Shandong University, Jinan, Shandong, China.
Pokaż więcej
Źródło :
The Journal of international medical research [J Int Med Res] 2021 Oct; Vol. 49 (10), pp. 3000605211047761.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Antipsychotic Agents*/adverse effects
Rhabdomyolysis*/chemically induced
Adult ; Benzodiazepines ; Female ; Humans ; Muscles ; Olanzapine/therapeutic use ; Young Adult
Czasopismo naukowe
Tytuł :
Late-Onset Dystonia With Low-Dose Olanzapine in an Older Person: A Case Report.
Autorzy :
See S; 1St. John's University, College of Pharmacy and Health Sciences, Queens, New York.
Daniel V; 2Montefiore Nyack Hospital, Nyack, New York.
Sanon M; 3Director of Inpatient Geriatric Medicine Clinical Services, Brookdale Dept. of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
Pokaż więcej
Źródło :
The Senior care pharmacist [Sr Care Pharm] 2021 Oct 01; Vol. 36 (10), pp. 493-500.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Antipsychotic Agents*/adverse effects
Dystonia*/chemically induced
Aged ; Benzodiazepines/adverse effects ; Female ; Humans ; Olanzapine/adverse effects ; Risperidone
Czasopismo naukowe
Tytuł :
Deprescribing anticholinergic medication in the community mental health setting: A quality improvement initiative.
Autorzy :
Gannon JM; University of Pittsburgh School of Medicine, 3550 Terrace St, Pittsburgh, PA, 15213, USA; University of Pittsburgh Medical Center Western Psychiatric Hospital, 3811 O'Hara Street, Pittsburgh, PA, 15213, USA. Electronic address: .
Lupu A; University of Pittsburgh Medical Center Western Psychiatric Hospital, 3811 O'Hara Street, Pittsburgh, PA, 15213, USA; University of Pittsburgh School of Pharmacy, 3501 Terrace St, Pittsburgh, PA, 15213, USA. Electronic address: .
Brar J; University of Pittsburgh Medical Center Western Psychiatric Hospital, 3811 O'Hara Street, Pittsburgh, PA, 15213, USA. Electronic address: .
Brandt M; Allegheny Health Network, 4818 Liberty Ave, Pittsburgh, PA, 15224, USA. Electronic address: .
Zawacki S; University of Pittsburgh Medical Center Western Behavioral Health, Community Behavioral Health Network, 3811 O'Hara Street, Pittsburgh, PA, 15213, USA. Electronic address: .
John S; University of Pittsburgh Medical Center Western Behavioral Health, Community Behavioral Health Network, 3811 O'Hara Street, Pittsburgh, PA, 15213, USA. Electronic address: .
Carl K; University of Pittsburgh Medical Center Western Behavioral Health, Community Behavioral Health Network, 3811 O'Hara Street, Pittsburgh, PA, 15213, USA. Electronic address: .
Chengappa KNR; University of Pittsburgh School of Medicine, 3550 Terrace St, Pittsburgh, PA, 15213, USA; University of Pittsburgh Medical Center Western Psychiatric Hospital, 3811 O'Hara Street, Pittsburgh, PA, 15213, USA. Electronic address: .
Pokaż więcej
Źródło :
Research in social & administrative pharmacy : RSAP [Res Social Adm Pharm] 2021 Oct; Vol. 17 (10), pp. 1841-1846. Date of Electronic Publication: 2020 Dec 19.
Typ publikacji :
Journal Article
MeSH Terms :
Antipsychotic Agents*/therapeutic use
Deprescriptions*
Adult ; Aged ; Cholinergic Antagonists ; Humans ; Mental Health ; Middle Aged ; Quality Improvement ; Quality of Life
Czasopismo naukowe
Tytuł :
A systematic review and pooled, patient-level analysis of predictors of mortality in neuroleptic malignant syndrome.
Autorzy :
Guinart D; Division of Psychiatry Research, The Zucker Hillside Hospital, Northwell Health, New York, NY, USA.; Center for Psychiatric Neuroscience, Feinstein Institutes for Medical Research, Manhasset, NY, USA.; Department of Psychiatry, Donald and Barbara Zucker School of Medicine at Northwell/Hofstra, Hempstead, NY, USA.; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Institut de Neuropsiquiatria i Addiccions (INAD), Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Departament de Psiquiatria, Universitat Autònoma de Barcelona, Barcelona, Spain.
Misawa F; Yamanashi Prefectural KITA Hospital, Yamanashi, Japan.
Rubio JM; Division of Psychiatry Research, The Zucker Hillside Hospital, Northwell Health, New York, NY, USA.; Center for Psychiatric Neuroscience, Feinstein Institutes for Medical Research, Manhasset, NY, USA.; Department of Psychiatry, Donald and Barbara Zucker School of Medicine at Northwell/Hofstra, Hempstead, NY, USA.
Pereira J; Division of Psychiatry Research, The Zucker Hillside Hospital, Northwell Health, New York, NY, USA.
de Filippis R; Division of Psychiatry Research, The Zucker Hillside Hospital, Northwell Health, New York, NY, USA.; Psychiatry Unit, Department of Health Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy.
Gastaldon C; Division of Psychiatry Research, The Zucker Hillside Hospital, Northwell Health, New York, NY, USA.; Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.
Kane JM; Division of Psychiatry Research, The Zucker Hillside Hospital, Northwell Health, New York, NY, USA.; Center for Psychiatric Neuroscience, Feinstein Institutes for Medical Research, Manhasset, NY, USA.; Department of Psychiatry, Donald and Barbara Zucker School of Medicine at Northwell/Hofstra, Hempstead, NY, USA.
Correll CU; Division of Psychiatry Research, The Zucker Hillside Hospital, Northwell Health, New York, NY, USA.; Center for Psychiatric Neuroscience, Feinstein Institutes for Medical Research, Manhasset, NY, USA.; Department of Psychiatry, Donald and Barbara Zucker School of Medicine at Northwell/Hofstra, Hempstead, NY, USA.; Department of Child and Adolescent Psychiatry, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Pokaż więcej
Źródło :
Acta psychiatrica Scandinavica [Acta Psychiatr Scand] 2021 Oct; Vol. 144 (4), pp. 329-341. Date of Electronic Publication: 2021 Aug 25.
Typ publikacji :
Journal Article; Review; Systematic Review
MeSH Terms :
Antipsychotic Agents*/adverse effects
Neuroleptic Malignant Syndrome*/epidemiology
Neuroleptic Malignant Syndrome*/etiology
Adult ; Aged ; Humans ; Incidence ; Male ; Odds Ratio ; Risk Factors
Czasopismo naukowe
Tytuł :
The Impact of Antipsychotic Dose Reduction on Clinical Outcomes and Health Care Resource Use Among Medicare Patients with Schizophrenia.
Autorzy :
Zichlin ML; Analysis Group, Inc., 111 Huntington Avenue, Fourteenth Floor, Boston, MA, 02199, USA.
Mu F; Analysis Group, Inc., 111 Huntington Avenue, Fourteenth Floor, Boston, MA, 02199, USA.
Leo S; Teva Pharmaceuticals, Parsippany, NJ, USA.
Ayyagari R; Analysis Group, Inc., 111 Huntington Avenue, Fourteenth Floor, Boston, MA, 02199, USA. .
Pokaż więcej
Źródło :
Clinical drug investigation [Clin Drug Investig] 2021 Oct; Vol. 41 (10), pp. 853-863. Date of Electronic Publication: 2021 Sep 04.
Typ publikacji :
Journal Article
MeSH Terms :
Antipsychotic Agents*/therapeutic use
Schizophrenia*/drug therapy
Aged ; Cohort Studies ; Delivery of Health Care ; Drug Tapering ; Humans ; Medicare ; Retrospective Studies ; United States
Czasopismo naukowe
Tytuł :
Regional brain network and behavioral alterations in EGR3 gene transfected rat model of schizophrenia.
Autorzy :
Gao W; Department of Radiology, China-Japan Friendship Hospital, No.2 Yinghuayuan East Street, Chaoyang District, Beijing, 100029, China.
Li G; School of Life Science, Beijing Institute of Technology, No.5 Zhongguancun South Street, Haidian District, Beijing, 100081, China.
Han X; Department of Radiology, China-Japan Friendship Hospital, No.2 Yinghuayuan East Street, Chaoyang District, Beijing, 100029, China.; Graduate School of Peking Union Medical College, Beijing, 100006, China.
Song Z; School of Life Science, Beijing Institute of Technology, No.5 Zhongguancun South Street, Haidian District, Beijing, 100081, China.
Zhao S; Changzhi Medical College, Shanxi, 046000, China.
Sun F; School of Life Science, Beijing Institute of Technology, No.5 Zhongguancun South Street, Haidian District, Beijing, 100081, China.
Ma H; School of Life Science, Beijing Institute of Technology, No.5 Zhongguancun South Street, Haidian District, Beijing, 100081, China.
Cui A; Anatomy Department of Changzhi Medical College, Shanxi, 046000, China.
Wang Y; Department of Radiology, China-Japan Friendship Hospital, No.2 Yinghuayuan East Street, Chaoyang District, Beijing, 100029, China.
Liu X; Department of Radiology, China-Japan Friendship Hospital, No.2 Yinghuayuan East Street, Chaoyang District, Beijing, 100029, China.
Chen Y; Department of Radiology, China-Japan Friendship Hospital, No.2 Yinghuayuan East Street, Chaoyang District, Beijing, 100029, China.
Zhang L; Department of Science and Education, Shangluo Central Hospital, Shangluo, 726000, China.
Ma G; Department of Radiology, China-Japan Friendship Hospital, No.2 Yinghuayuan East Street, Chaoyang District, Beijing, 100029, China. .
Tang X; School of Life Science, Beijing Institute of Technology, No.5 Zhongguancun South Street, Haidian District, Beijing, 100081, China. .
Pokaż więcej
Źródło :
Brain imaging and behavior [Brain Imaging Behav] 2021 Oct; Vol. 15 (5), pp. 2606-2615. Date of Electronic Publication: 2021 Mar 15.
Typ publikacji :
Journal Article
MeSH Terms :
Antipsychotic Agents*/therapeutic use
Schizophrenia*/diagnostic imaging
Schizophrenia*/drug therapy
Schizophrenia*/genetics
Early Growth Response Protein 3/*genetics
Animals ; Brain/diagnostic imaging ; Magnetic Resonance Imaging ; Memory, Short-Term ; Rats ; Risperidone/therapeutic use ; Transfection
Czasopismo naukowe
Tytuł :
Clozapine-related immunodeficiency: Implications for Parkinson's disease psychosis in the context of the COVID-19 pandemic.
Autorzy :
Aubignat M; Department of Neurology and Expert Center for Parkinson's disease, University Hospital of Amiens, Amiens, France. Electronic address: .
Pokaż więcej
Źródło :
Revue neurologique [Rev Neurol (Paris)] 2021 Oct; Vol. 177 (8), pp. 849-851. Date of Electronic Publication: 2021 Jun 24.
Typ publikacji :
Editorial
MeSH Terms :
Antipsychotic Agents*/adverse effects
COVID-19*
Clozapine*/adverse effects
Parkinson Disease*/complications
Parkinson Disease*/drug therapy
Parkinson Disease*/epidemiology
Psychotic Disorders*/drug therapy
Psychotic Disorders*/epidemiology
Humans ; Pandemics ; SARS-CoV-2
Opinia redakcyjna
Tytuł :
What about regular hematological monitoring during clozapine treatment? A compliance analysis using the French health insurance database.
Autorzy :
Laforgue EJ; Clinical Pharmacology Department, Nantes University Hospital, Nantes, France.; INSERM UMR 1246 SPHERE (Methods in Patients-centered Outcomes and HEalth Research), Nantes and Tours Universities, France.
Istvan M; Clinical Pharmacology Department, Nantes University Hospital, Nantes, France.; INSERM UMR 1246 SPHERE (Methods in Patients-centered Outcomes and HEalth Research), Nantes and Tours Universities, France.
Guerlais M; Clinical Pharmacology Department, Nantes University Hospital, Nantes, France.
Chaslerie A; Medical Department, French Health Insurance System, Nantes, France.
Artarit P; Medical Department, French Health Insurance System, Nantes, France.
Vallot G; Medical Department, French Health Insurance System, Nantes, France.
Jolliet P; Clinical Pharmacology Department, Nantes University Hospital, Nantes, France.; INSERM UMR 1246 SPHERE (Methods in Patients-centered Outcomes and HEalth Research), Nantes and Tours Universities, France.
Grall-Bronnec M; INSERM UMR 1246 SPHERE (Methods in Patients-centered Outcomes and HEalth Research), Nantes and Tours Universities, France.; Addictology and Liaison-Psychiatry Department, Nantes University Hospital, Nantes, France.
Victorri-Vigneau C; Clinical Pharmacology Department, Nantes University Hospital, Nantes, France.; INSERM UMR 1246 SPHERE (Methods in Patients-centered Outcomes and HEalth Research), Nantes and Tours Universities, France.
Pokaż więcej
Źródło :
Expert opinion on drug safety [Expert Opin Drug Saf] 2021 Oct; Vol. 20 (10), pp. 1247-1256. Date of Electronic Publication: 2021 Jun 14.
Typ publikacji :
Journal Article
MeSH Terms :
Agranulocytosis/*diagnosis
Antipsychotic Agents/*adverse effects
Clozapine/*adverse effects
Drug Monitoring/*methods
Agranulocytosis/chemically induced ; Antipsychotic Agents/administration & dosage ; Clozapine/administration & dosage ; Databases, Factual ; Female ; France ; Guideline Adherence ; Hospitalization/statistics & numerical data ; Humans ; Insurance, Health ; Leukocyte Count ; Male ; Middle Aged ; Schizophrenia/drug therapy
Czasopismo naukowe
Tytuł :
Can antipsychotic use protect from COVID-19?
Autorzy :
Dratcu L; Maudsley Hospital, South London and Maudsley NHS Foundation Trust, Denmark Hill, London SE5 8AZ, United Kingdom. Electronic address: .
Boland X; Maudsley Hospital, South London and Maudsley NHS Foundation Trust, Denmark Hill, London SE5 8AZ, United Kingdom. Electronic address: .
Pokaż więcej
Źródło :
Schizophrenia research [Schizophr Res] 2021 Oct; Vol. 236, pp. 1-2. Date of Electronic Publication: 2021 Jul 30.
Typ publikacji :
Letter; Comment
MeSH Terms :
Antipsychotic Agents*/therapeutic use
COVID-19*
Cytokines ; Humans ; SARS-CoV-2
Opinia redakcyjna
Tytuł :
Severe and persistent mental illness (SPMI) in pregnancy and breastfeeding: focus on second-generation long acting injectable antipsychotics.
Autorzy :
Orsolini L; Unit of Clinical Psychiatry, Department of Clinical Neurosciences/DIMSC, School of Medicine, Polytechnic University of Marche, Ancona, Italy.
Sceusa F; Unit of Clinical Psychiatry, Department of Clinical Neurosciences/DIMSC, School of Medicine, Polytechnic University of Marche, Ancona, Italy.
Pompili S; Unit of Clinical Psychiatry, Department of Clinical Neurosciences/DIMSC, School of Medicine, Polytechnic University of Marche, Ancona, Italy.
Mauro A; Unit of Clinical Psychiatry, Department of Clinical Neurosciences/DIMSC, School of Medicine, Polytechnic University of Marche, Ancona, Italy.
Salvi V; Unit of Clinical Psychiatry, Department of Clinical Neurosciences/DIMSC, School of Medicine, Polytechnic University of Marche, Ancona, Italy.
Volpe U; Unit of Clinical Psychiatry, Department of Clinical Neurosciences/DIMSC, School of Medicine, Polytechnic University of Marche, Ancona, Italy.
Pokaż więcej
Źródło :
Expert opinion on drug safety [Expert Opin Drug Saf] 2021 Oct; Vol. 20 (10), pp. 1207-1224. Date of Electronic Publication: 2021 Jul 28.
Typ publikacji :
Journal Article; Systematic Review
MeSH Terms :
Antipsychotic Agents/*administration & dosage
Mental Disorders/*drug therapy
Pregnancy Complications/*drug therapy
Antipsychotic Agents/adverse effects ; Breast Feeding ; Delayed-Action Preparations ; Female ; Humans ; Infant, Newborn ; Injections ; Mental Disorders/physiopathology ; Pregnancy ; Pregnancy Complications/psychology ; Pregnancy Outcome ; Randomized Controlled Trials as Topic ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
Efficacy and safety of clozapine in psychotic disorders-a systematic quantitative meta-review.
Autorzy :
Wagner E; Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany. .
Siafis S; Department of Psychiatry and Psychotherapy, School of Medicine, Technische Universität München, Klinikum rechts der Isar, Munich, Germany.
Fernando P; Department of Psychiatry, Psychotherapy and Psychosomatics of the University Augsburg, Bezirkskrankenhaus Augsburg, Medical Faculty, University of Augsburg, Augsburg, Germany.
Falkai P; Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.
Honer WG; Department of Psychiatry, The University of British Columbia, Vancouver, Canada.
Röh A; Department of Psychiatry, Psychotherapy and Psychosomatics of the University Augsburg, Bezirkskrankenhaus Augsburg, Medical Faculty, University of Augsburg, Augsburg, Germany.
Siskind D; School of Medicine, University of Queensland, Brisbane, Australia.; Metro South Addiction and Mental Health Service, Brisbane, Australia.
Leucht S; Department of Psychiatry and Psychotherapy, School of Medicine, Technische Universität München, Klinikum rechts der Isar, Munich, Germany.
Hasan A; Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.; Department of Psychiatry, Psychotherapy and Psychosomatics of the University Augsburg, Bezirkskrankenhaus Augsburg, Medical Faculty, University of Augsburg, Augsburg, Germany.
Pokaż więcej
Źródło :
Translational psychiatry [Transl Psychiatry] 2021 Sep 22; Vol. 11 (1), pp. 487. Date of Electronic Publication: 2021 Sep 22.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Antipsychotic Agents*/adverse effects
Bipolar Disorder*/drug therapy
Clozapine*/adverse effects
Psychotic Disorders*/drug therapy
Schizophrenia*/drug therapy
Humans
Czasopismo naukowe
Tytuł :
40-Hz Auditory Steady-State Responses Characterize Circuit Dysfunctions and Predict Clinical Outcomes in Clinical High-Risk for Psychosis Participants: A Magnetoencephalography Study.
Autorzy :
Grent-'t-Jong T; Institute of Neuroscience and Psychology, University of Glasgow, Glasgow, United Kingdom; Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany.
Gajwani R; Mental Health and Wellbeing, Institute of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom.
Gross J; Institute of Neuroscience and Psychology, University of Glasgow, Glasgow, United Kingdom; Institute for Biomagnetism and Biosignalanalysis, University of Muenster, Muenster, Germany.
Gumley AI; Mental Health and Wellbeing, Institute of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom.
Krishnadas R; Institute of Neuroscience and Psychology, University of Glasgow, Glasgow, United Kingdom.
Lawrie SM; Department of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom.
Schwannauer M; Department of Clinical Psychology, University of Edinburgh, Edinburgh, United Kingdom.
Schultze-Lutter F; Department of Psychiatry and Psychotherapy, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany; Department of Psychology and Mental Health, Faculty of Psychology, Airlangga University, Airlangga, Indonesia; University Hospital of Child and Adolescent Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland.
Uhlhaas PJ; Institute of Neuroscience and Psychology, University of Glasgow, Glasgow, United Kingdom; Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany. Electronic address: .
Pokaż więcej
Źródło :
Biological psychiatry [Biol Psychiatry] 2021 Sep 15; Vol. 90 (6), pp. 419-429. Date of Electronic Publication: 2021 Mar 23.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antipsychotic Agents*
Auditory Cortex*
Psychotic Disorders*
Acoustic Stimulation ; Electroencephalography ; Evoked Potentials, Auditory ; Humans ; Magnetoencephalography
Czasopismo naukowe
Tytuł :
Reply to: Individualized Diagnostic and Prognostic Models for Psychosis Risk Syndromes: Do Not Underestimate Antipsychotic Exposure.
Autorzy :
Sanfelici R; Department of Psychiatry and Psychotherapy, Ludwig Maximilian University of Munich, Munich, Germany.
Antonucci LA; Department of Education, Psychology and Communication, University of Bari Aldo Moro, Bari, Italy.
Dwyer DB; Department of Psychiatry and Psychotherapy, Ludwig Maximilian University of Munich, Munich, Germany.
Koutsouleris N; Department of Psychiatry and Psychotherapy, Ludwig Maximilian University of Munich, Munich, Germany; Max Planck Institute of Psychiatry, Munich, Germany; Institute of Psychiatry, Psychology and Neuroscience, King's College London, United Kingdom. Electronic address: .
Pokaż więcej
Źródło :
Biological psychiatry [Biol Psychiatry] 2021 Sep 15; Vol. 90 (6), pp. e37-e38. Date of Electronic Publication: 2021 May 15.
Typ publikacji :
Letter; Comment
MeSH Terms :
Antipsychotic Agents*/adverse effects
Psychotic Disorders*/diagnosis
Psychotic Disorders*/drug therapy
Humans ; Prognosis ; Syndrome
Opinia redakcyjna
Tytuł :
Individualized Diagnostic and Prognostic Models for Psychosis Risk Syndromes: Do Not Underestimate Antipsychotic Exposure.
Autorzy :
Raballo A; Section of Psychiatry, Clinical Psychology and Rehabilitation, Department of Medicine, University of Perugia, Italy; Center for Translational, Phenomenological and Developmental Psychopathology, Perugia University Hospital, Perugia, Italy. Electronic address: .
Poletti M; Child and Adolescent Neuropsychiatry Service, Department of Mental Health and Pathological Addiction, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Preti A; Department of Neuroscience, University of Turin, Turin, Italy.
Pokaż więcej
Źródło :
Biological psychiatry [Biol Psychiatry] 2021 Sep 15; Vol. 90 (6), pp. e33-e35. Date of Electronic Publication: 2021 May 15.
Typ publikacji :
Letter; Comment
MeSH Terms :
Antipsychotic Agents*/adverse effects
Psychotic Disorders*/diagnosis
Psychotic Disorders*/drug therapy
Humans ; Prognosis ; Syndrome
Opinia redakcyjna
Tytuł :
Rapid-onset clozapine-induced hyperglycaemia: pathways of glycaemic dysregulation.
Autorzy :
Barbosa M; Endocrinology Department, Braga Hospital, Braga, Portugal .
Fernandes V; Endocrinology Department, Braga Hospital, Braga, Portugal.
Pokaż więcej
Źródło :
BMJ case reports [BMJ Case Rep] 2021 Sep 13; Vol. 14 (9). Date of Electronic Publication: 2021 Sep 13.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Antipsychotic Agents*/adverse effects
Clozapine*/adverse effects
Hyperglycemia*/chemically induced
Hyperglycemia*/drug therapy
Schizophrenia*/drug therapy
Blood Glucose ; Female ; Humans ; Middle Aged
Czasopismo naukowe
Tytuł :
Use of antipsychotic drugs and cholinesterase inhibitors and risk of falls and fractures: self-controlled case series.
Autorzy :
Wang GH; School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Man KKC; Research Department of Practice and Policy, UCL School of Pharmacy, London, UK.
Chang WH; Department of Psychiatry, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Department of Psychiatry, National Cheng Kung University Hospital, Dou-Liou Branch, Yunlin, Taiwan.
Liao TC; School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Lai EC; School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan .
Pokaż więcej
Źródło :
BMJ (Clinical research ed.) [BMJ] 2021 Sep 09; Vol. 374, pp. n1925. Date of Electronic Publication: 2021 Sep 09.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Accidental Falls/*statistics & numerical data
Antipsychotic Agents/*administration & dosage
Cholinesterase Inhibitors/*administration & dosage
Aged ; Aged, 80 and over ; Antipsychotic Agents/adverse effects ; Cholinesterase Inhibitors/adverse effects ; Databases, Factual ; Female ; Fractures, Bone/epidemiology ; Humans ; Incidence ; Male ; Neurocognitive Disorders/drug therapy ; Risk Assessment ; Taiwan
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies